Ecora Royalties PLC
ECOR.TO News Today: Stay Updated with the Latest Ecora Royalties PLC News in Real Time
Find ECOR.TO news now at Meyka AI. Stay informed with the latest Ecora Royalties PLC stocks updates, including price news, market analysis, and expert insights.
Volume spike IFRD.AS iShares France Govt Bond EURONEXT pre-market 01 Apr 2026: watch yield gap
IFRD.AS stock sees a pre-market volume spike on EURONEXT; analyze yield trade, dividend and short-term targets
USD/CAD on March 31: Oil Spike, Fed Watch Drive Loonie Volatility
USD/CAD today hovers near 1.39 as $100 oil, Middle East risk, and Jerome Powell remarks keep volatility high. What it means for the Canadian dollar and investors.
FECHF $3.49: Fidelity China Special Situations PLC (PNK) high-volume mover 31 Mar 2026
FECHF stock trades at $3.49 on 31 Mar 2026; MEYKA analysis, grade, and a $1.58 model projection for investors
IQL.DE iQ International AG jumps 125% pre-market (XETRA) on 31 Mar 2026: early upside to €0.09
IQL.DE stock jumps 125% pre-market to €0.045 on 31 Mar 2026; Meyka AI projects a €0.09 target for analysis and outlook
MCD Stock Today: March 30 — Iran Conflict, Energy Costs Squeeze Margins
McDonald’s stock faces pressure as the Iran conflict lifts energy and commodity costs, squeezing margins while UK investors weigh valuation, dividends, and April value promos. See price, technicals, $
€0.037 Drop After Hours: MBH Corporation PLC (M8H.DE XETRA) liquidity alert
M8H.DE stock falls to €0.037 after hours on 30 Mar 2026; extreme drop, low volume and a Meyka AI B grade
ITRM Iterum Therapeutics plc NASDAQ -66% intraday 30 Mar 2026: heavy volume
ITRM stock down 66% intraday on NASDAQ 30 Mar 2026 with huge volume; short-term outlook and Meyka AI forecast compare risks and upside
STSR Star Energy Group PLC (PNK) at $2.62 on 30 Mar 2026: check analyst price targets
STSR stock at $2.62 on PNK — quick analysis, Meyka forecast and price targets for 30 Mar 2026
Eli Lilly Expands AI Drug Discovery Deal with Insilico Medicine
The pharmaceutical industry is changing fast. And at the center of this shift is Eli Lilly. In March 2026, Eli Lilly expanded its partnership with Insilico Medicine. The deal could reach $2.75 billion, making it one of the biggest AI-driven drug discovery agreements so far. We from the healthcare and tech space view this as…